These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32776000)

  • 1. Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology.
    Vyas S; Dhoble S; Ghodake V; Patravale V
    Int J Pharm X; 2020 Dec; 2():100053. PubMed ID: 32776000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs.
    Dhakal S; Renu S; Ghimire S; Shaan Lakshmanappa Y; Hogshead BT; Feliciano-Ruiz N; Lu F; HogenEsch H; Krakowka S; Lee CW; Renukaradhya GJ
    Front Immunol; 2018; 9():934. PubMed ID: 29770135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safe Subunit Green Vaccines Confer Robust Immunity and Protection against Mucosal Brucella Infection in Mice.
    Abushahba MF; Dadelahi AS; Lemoine EL; Skyberg JA; Vyas S; Dhoble S; Ghodake V; Patravale VB; Adamovicz JJ
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19.
    Shim S; Soh SH; Im YB; Park HE; Cho CS; Kim S; Yoo HS
    Int J Med Microbiol; 2020 Jan; 310(1):151362. PubMed ID: 31676233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S; Singh D; Gupta M; Bhatnagar R
    Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Trends and Future Challenges of Nanovaccine Delivery
    Dewangan HK; Raghuvanshi A; Shah K
    Curr Drug Targets; 2023; 24(3):261-273. PubMed ID: 36475350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiadjuvant polysaccharide-amino acid-lipid (PAL) subunit nanovaccine generates robust systemic and lung-specific mucosal immune responses against SARS-CoV-2 in mice.
    Pandey B; Wang Z; Jimenez A; Bhatia E; Jain R; Beach A; Maniar D; Hosten J; O'Farrell L; Vantucci C; Hur D; Noel R; Ringuist R; Smith C; Ochoa MA; Roy K
    bioRxiv; 2023 May; ():. PubMed ID: 37215018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of Th2-related immune responses and production of systemic IgA in mice intranasally immunized with Brucella abortus malate dehydrogenase loaded chitosan nanoparticles.
    Soh SH; Shim S; Im YB; Park HT; Cho CS; Yoo HS
    Vaccine; 2019 Mar; 37(12):1554-1564. PubMed ID: 30792035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers.
    Dewangan HK; Pandey T; Maurya L; Singh S
    Int J Biol Macromol; 2018 May; 111():804-812. PubMed ID: 29343454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
    Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
    Hayden CA; Fischer ME; Andrews BL; Chilton HC; Turner DD; Walker JH; Tizard IR; Howard JA
    Vaccine; 2015 Jun; 33(25):2881-6. PubMed ID: 25944300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.
    Abkar M; Lotfi AS; Amani J; Eskandari K; Ramandi MF; Salimian J; Brujeni GN; Alamian S; Kamali M; Koushki H
    Vet Res Commun; 2015 Dec; 39(4):217-28. PubMed ID: 26395469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasally administered anti-Brucella subunit vaccine formulation induces protective immune responses against nasal Brucella challenge.
    Senevirathne A; Hewawaduge C; Hajam IA; Lalsiamthara J; Lee JH
    Vet Microbiol; 2019 Jan; 228():112-118. PubMed ID: 30593355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyanhydride nanovaccine against swine influenza virus in pigs.
    Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
    Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The
    Verma R; Sahu R; Dixit S; Duncan SA; Giambartolomei GH; Singh SR; Dennis VA
    Front Immunol; 2018; 9():2369. PubMed ID: 30374357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CpG-ODN-adjuvanted polyanhydride-based intranasal influenza nanovaccine in pigs.
    Dhakal S; Ghimire S; Renu S; Ross KA; Lakshmanappa YS; Hogshead BT; Bernardo P; Lee CW; Wannemuehler MJ; Narasimhan B; Renukaradhya GJ
    Vet Microbiol; 2019 Oct; 237():108401. PubMed ID: 31585639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
    Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified chitosan-based nanoadjuvants enhance immunogenicity of protein antigens after mucosal vaccination.
    Sinani G; Sessevmez M; Gök MK; Özgümüş S; Alpar HO; Cevher E
    Int J Pharm; 2019 Oct; 569():118592. PubMed ID: 31386881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: Dry powder formulation for nasal immunization in rabbits.
    Dehghan S; Kheiri MT; Abnous K; Eskandari M; Tafaghodi M
    Microb Pathog; 2018 Feb; 115():74-85. PubMed ID: 29223454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.